Edurant and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Edurant (rilpivirine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Tivicay, and have Hiv infection.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Edurant. It is created by eHealthMe based on reports of 2,231 people who have side effects when taking Edurant from the FDA, and is updated regularly.

What is Edurant?

Edurant has active ingredients of rilpivirine hydrochloride. eHealthMe is studying from 2,238 Edurant users. Check the latest studies of Edurant.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,401 drugs and 3,349 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jul, 11, 2026

2,231 people reported to have side effects when taking Edurant.
Among them, 19 people (0.85%) have Swallowing difficulty.

Could Edurant cause Swallowing difficulty?

Among these 19 people:

How long have people been on Edurant when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Edurant? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Swallowing difficulty when taking Edurant? *

What are other drugs people take besides Edurant? *

What are other side effects people have besides Swallowing difficulty? *

Chills (felling of cold): 3 people, 15.79%
Muscle Rigidity (muscle stiffness): 3 people, 15.79%
Gait Disturbance: 3 people, 15.79%
Oesophageal Carcinoma (cancer tumour of oesophagus): 3 people, 15.79%
Eye Movements - Uncontrollable: 3 people, 15.79%
Oral Pain: 3 people, 15.79%
Multiple System Atrophy (degeneration of nerve cells in specific areas of the brain): 3 people, 15.79%
Dysstasia (difficulty in standing): 3 people, 15.79%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 3 people, 15.79%
Hypophagia (reduced food intake): 3 people, 15.79%

What are the existing conditions these people have? *

Hiv Infection: 9 people, 47.37%
Oedema (fluid collection in tissue): 2 people, 10.53%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 10.53%
Mouth Ulcers: 2 people, 10.53%
Chills (felling of cold): 2 people, 10.53%
Oral Candidiasis (fungal infection of mouth): 1 person, 5.26%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 1 person, 5.26%
Hepatitis B: 1 person, 5.26%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Edurant and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Edurant:

Edurant (2,238 reports)

Browse all side effects of Edurant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,401 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,349 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rilpivirine hydrochloride (the active ingredients of Edurant) and Edurant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.